All News

Mainstay Medical to Showcase ReActiv8 and Key Clinical Data at the 13th German Spine Congress of the DWG

December 03, 2018 DUBLIN–(BUSINESS WIRE)–Regulatory News: Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and Euronext Dublin: MSTY.IE), a medical device company focused on commercializing ReActiv8®, an implantable restorative neurostimulation system designed to treat an underlying cause of disabling Chronic Low Back Pain, today announces that it will participate in the 13th German […]

Olympus 3D/FlexDex Named 2018 Excellence in Surgical Products Award Winner

CENTER VALLEY, Pa., Dec. 3, 2018 /PRNewswire/ — Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has been recognized with the Surgical Products’ 2018 Excellence in Surgical Products (ESP) Award, distinguishing ENDOEYE FLEX 3D and FlexDex® (3D/FlexDex) as the winner in the […]

Carmel spine surgeon wins $112M verdict in royalty battle with Medtronic

November 30, 2018 / John Russell Dr. Rick C. Sasso, an Indiana spine surgeon and inventor, has won a sweeping, five-year legal battle against medical-device giant Medtronic, with a jury this week awarding him $112 million in damages. Sasso, 58, president of Carmel-based Indiana Spine Group, had claimed that Medtronic had violated a contract by not […]

Global Hip & Knee Reconstruction Devices Market Outlook to 2027 – Computer-assisted Total Hip Replacement Surgery is One of the Hottest Revolutions – ResearchAndMarkets.com

November 30, 2018 DUBLIN–(BUSINESS WIRE)–The “Global Hip & Knee Reconstruction Devices Market Analysis & Trends – Industry Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Hip & Knee Reconstruction Devices Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rising […]

LimaCorporate Celebrates the Launch of the SMR TT Hybrid Glenoid, Expanding the Shoulder Portfolio

UDINE, Italy, November 30, 2018 /PRNewswire/ — LimaCorporate is pleased to announce the launch of the SMR TT Hybrid Glenoid, the latest addition to the SMR Shoulder System. The SMR Shoulder System is a total shoulder replacement designed to provide surgeons a wide range of options to address the different patients’ pathologies. There have been over 150,000 implants […]

Jackson hospital first in nation to get next-gen spinal surgery technology

Nov 28, 2018 / By Taylor DesOrmeau JACKSON, MI – It looks like a tablet but instead of connecting to headphones, the wires protruding from this new device at Henry Ford Allegiance Health connects to stickers – which are attached to the arms and legs of patients undergoing surgery. The new device is called a Sentio generation 2 […]

Histogenics and FDA Continue to Discuss NeoCartĀ® Phase 3 Clinical Trial Data and Potential Regulatory Pathway

WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain relief and restored function, today provided an update on the NeoCart regulatory pathway based on its ongoing dialogue with the U.S. Food and Drug Administration (the FDA).  Since […]

WishBone Medical, Inc. acquires Response Ortho

WARSAW, Ind., Nov. 28, 2018 (GLOBE NEWSWIRE) — WishBone Medical, Inc. announces the acquisition of Response Ortho. Response Ortho has a complete pediatric line of external and internal fixation and deformity correction products. Response Ortho has been in business for fourteen years and has built a modern, high-tech manufacturing facility with access to an experienced […]

FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain

November 28, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced the FDA has cleared its Investigational New Drug (IND) protocol for human trials in the U.S., considered to be the first IND approval for a fibroblast cell therapy […]

FDA Clears SpinalCyte IND Application for Universal Donor Cell Therapy to Treat Lower Back Pain

November 28, 2018 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using its universal donor product, CybroCell™, today announced the FDA has cleared its Investigational New Drug (IND) protocol for human trials in the U.S., considered to be the first IND approval for a fibroblast cell therapy […]

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1